ESG News For Organon & Co

Today, Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, embarks on the next phase of programming for “Her Plan is Her Power,” to improve access and outcomes related to unplanned pregnancy in the U.S.

Her Promise Access Initiative helped prevent 57 million unplanned pregnancies putting the company approximately halfway to its goal of preventing 120 million unplanned pregnancies by 2030

Second annual report highlights company’s advancements with a focus on innovation and access to ensure a healthier, more sustainable future for women worldwide.

Recap of CSR stories on Business Wire

Building on Organon’s Prior FP2030 Commitment, the Company Announces $30 Million in New Funding to Fuel Global Action and Community-Driven Solutions Needed by the 121 Million Women and Girls Who Experience Unplanned Pregnancies Each Year

Recap of CSR stories on Business Wire

Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better healthLaunch of Her Promise ESG platform creates a framework by which Organon aims to advance innovation and progress in women’s health and contribute to UN Sustainable Development GoalsThrough the Her Promise Access Initiative, Organon’s goal is to provide 100 million girls and women in low- and middle-income countries with affordable access to contraceptive options by 2030Funding to global NGO Women Deliver for their Young Leaders Program and other advocacy work, including support for young people around the world to advocate for and advance women’s health and gender equality

Chair C. Robert Kidder to Retire from Board of Directors

Building on its vision to create a better and healthier every day for every woman, Organon launches Public Service Announcement video to challenge and help reduce stigma of global public health issue